Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
The price of Soleno Therapeutics Inc (NASDAQ: SLNO) closed at $74.66 in the last session, up 1.29% from day before closing price of $73.71. In other words, the price has increased by $1.29 from its previous closing price. On the day, 1.06 million shares were traded.
Ratios:
We take a closer look at SLNO’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 15.68 and its Current Ratio is at 15.68. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.21.
On December 02, 2024, Stifel reiterated its Buy ratingand also kept the price unchanged to $74.
Robert W. Baird reiterated its Outperform rating for the stock on December 02, 2024, and also maintained the target price at $72.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Apr 01 ’25 when Hirano Patricia C sold 3,782 shares for $70.11 per share. The transaction valued at 265,156 led to the insider holds 27,036 shares of the business.
PATRICIA HIRANO bought 3,782 shares of SLNO for $265,156 on Apr 01 ’25. On Mar 28 ’25, another insider, Pauls Matthew, who serves as the Director of the company, sold 5,937 shares for $71.55 each. As a result, the insider received 424,797 and left with 6,500 shares of the company.
Stock Price History:
Over the past 52 weeks, SLNO has reached a high of $76.60, while it has fallen to a 52-week low of $36.93. The 50-Day Moving Average of the stock is 22.55%, while the 200-Day Moving Average is calculated to be 42.00%.
Shares Statistics:
A total of 45.70M shares are outstanding, with a floating share count of 39.61M. Insiders hold about 20.63% of the company’s shares, while institutions hold 80.25% stake in the company.
